Processa Pharmaceuticals, Inc. (PCSA)

NASDAQ: PCSA · Real-Time Price · USD

1.790

+0.060 (3.47%)

Oct 20, 2026, 4:00 PM EDT - Market closed

Processa Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.2	5.54	1.19	4.71	6.5	16.5
Cash & Short-Term Investments	0.2	5.54	1.19	4.71	6.5	16.5
Cash Growth	-97.17%	364.77%	-74.69%	-27.64%	-60.58%	7.01%
Other Receivables	-	-	-	-	-	0.07
Receivables	-	-	-	-	-	0.07
Prepaid Expenses	1.4	0.13	0.69	0.93	1.88	1.76
Other Current Assets	0.47	-	-	-	-	-
Total Current Assets	2.07	5.67	1.88	5.63	8.39	18.33
Property, Plant & Equipment	0	0	0.08	0.15	0.23	0.07
Other Intangible Assets	-	-	-	-	-	8.06
Other Long-Term Assets	-	2.14	1.27	0.01	0.01	0.01
Total Assets	2.07	7.81	3.23	5.79	8.62	26.46

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.66	1.06	0.88	0.31	0.33	0.22
Accrued Expenses	0.73	1.18	0.58	0.15	0.4	0.28
Current Portion of Leases	-	-	0.07	0.08	0.08	0.07
Other Current Liabilities	-	-	-	0.19	0.19	0.4
Total Current Liabilities	2.39	2.24	1.53	0.73	1	0.97
Long-Term Leases	-	-	0	0.07	0.15	0.01
Total Liabilities	2.39	2.24	1.53	0.8	1.15	0.98

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	107.11	106.66	89.22	80.66	72.02	62.31
Retained Earnings	-107.43	-100.78	-87.22	-75.37	-64.25	-36.82
Treasury Stock	-	-0.3	-0.3	-0.3	-0.3	-
Shareholders' Equity	-0.32	5.58	1.7	4.99	7.47	25.49
Total Liabilities & Equity	2.07	7.81	3.23	5.79	8.62	26.46

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	0.07	0.15	0.23	0.08
Net Cash (Debt)	0.2	5.54	1.12	4.56	6.27	16.42
Net Cash Growth	-97.16%	395.34%	-75.46%	-27.39%	-61.79%	8.82%
Net Cash Per Share	0.08	4.23	9.13	86.84	194.73	535.89
Filing Date Shares Outstanding	2.79	2.66	0.21	0.11	0.05	0.03
Total Common Shares Outstanding	2.79	2.57	0.15	0.05	0.03	0.03
Working Capital	-0.32	3.43	0.35	4.9	7.39	17.36
Book Value Per Share	-0.11	2.17	11.45	96.99	232.94	811.11
Tangible Book Value	-0.32	5.58	1.7	4.99	7.47	17.43
Tangible Book Value Per Share	-0.11	2.17	11.45	96.99	232.94	554.69

SEC Filings: 10-K · 10-Q